HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An epidemic of lung cancer due to chloromethyl ethers. 30 years of observation.

Abstract
A cohort of 125 chemical workers was established in 1963 to investigate an epidemic of lung cancer caused by industrial exposure to chloromethyl ethers (CME). Ninety-three of the men were exposed to CME, and approximate estimates of exposure were made. Standardized mortality ratios (SMRs) were calculated for lung cancer, based on Philadelphia city rates. Over 30 years of observation, 25 of 67 deaths were due to lung cancer, with a dose-response relationship. SMRs were elevated only among 59 moderately and heavily exposed workers, peaked at 23.1 in the first decade, and then declined to 7.4 and 7.9 in later decades. The mean latency period from onset of exposure to death was 21 to 25 years and was inversely related to cumulative exposure. Three of 12 heavily exposed cases occurred in nonsmokers. Small cell carcinoma accounted for 80% of the moderately and heavily exposed cases.
AuthorsW Weiss, D Nash
JournalJournal of occupational and environmental medicine (J Occup Environ Med) Vol. 39 Issue 10 Pg. 1003-9 (Oct 1997) ISSN: 1076-2752 [Print] United States
PMID9343765 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carcinogens
  • Bis(Chloromethyl) Ether
Topics
  • Adult
  • Aged
  • Bis(Chloromethyl) Ether (adverse effects)
  • Carcinogens
  • Cause of Death
  • Chemical Industry
  • Cohort Studies
  • Disease Outbreaks
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms (chemically induced, mortality)
  • Male
  • Middle Aged
  • Occupational Diseases (chemically induced, mortality)
  • Occupational Exposure (adverse effects)
  • Philadelphia (epidemiology)
  • Risk Factors
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: